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Abstract
Cytochrome P450c17 (P450 17A1, CYP17A1) is a critical enzyme in the synthesis of andro-
gens and is now a target enzyme for the treatment of prostate cancer. Cytochrome
P450c17 can exhibit either one or two physiological enzymatic activities differentially regu-
lated by cytochrome b5. How this is achieved remains unknown. Here, comprehensive in
silico, in vivo and in vitro analyses were undertaken. Fluorescence Resonance Energy
Transfer analysis showed close interactions within living cells between cytochrome
P450c17 and cytochrome b5. In silicomodeling identified the sites of interaction and con-
firmed that E48 and E49 residues in cytochrome b5 are essential for activity. Quartz crystal
microbalance studies identified specific protein-protein interactions in a lipid membrane.
Voltammetric analysis revealed that the wild type cytochrome b5, but not a mutated, E48G/
E49G cyt b5, altered the kinetics of electron transfer between the electrode and the
P450c17. We conclude that cytochrome b5 can influence the electronic conductivity of cyto-
chrome P450c17 via allosteric, protein-protein interactions.
Introduction
Cytochrome P450 (P450) enzymes are ubiquitous throughout nature, utilizing a heme moiety
at their active site with the electrons delivered via a protein redox pathway for hydroxylation of
substrates [1]. Our current understanding of mammalian P450 biochemistry is derived mostly
from studies on hepatic P450 enzymes. These differ from steroidogenic P450s in two funda-
mental ways. The hepatic P450s typically catalyze mono-hydroxylations needed to solubilize
xenobiotics, required to assist with their excretion from the body. They have large, flexible
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active site cavities that accommodate numerous substrates. In comparison, the steroidogenic
P450s catalyze multiple hydroxylations and carbon-carbon bond cleavage. Also, the active site
cavities are typically much smaller and accommodate only a narrow range of substrates. In
addition, the activities of both groups of P450s require different ratios of the redox partner pro-
tein, NADPH-cytochrome P450 oxido-reductase (CPR). The ratio of P450 to CPR in hepatic
tissues is large whereas in steroidogenic tissues it is believed to be much lower [2–4].
The steroidogenic enzyme cytochrome P450 17α-hydroxylase (P450c17; encoded by
CYP17A1) is an enzyme needed to synthesize both androgens (male hormones) and glucocorti-
coids (e.g. cortisol, essential for metabolism) from pregnenolone [5, 6]. P450c17 has a single
enzymatic activity, 17α-hydroxylase, in the zona fasciculata of the adrenal gland, which pro-
duces cortisol. However, it has two activities, 17α-hydroxylase and 17,20-lyase, in the gonads
and in the adrenal zona reticularis. These two activities are essential for the conversion of preg-
nenolone to dehydroepiandrosterone (DHEA), required for androgen synthesis. The first enzy-
matic activity, 17α-hydroxylase, is a single hydroxylation and the second requires an additional
hydroxylation leading to the breaking of the bond between carbons 17 and 20 [7]. Therefore,
both activities of P450c17 require electrons from NADPH delivered via CPR.
Close examination of the cellular locations of P450c17 revealed that the gonads and the
adrenal zona reticularis are also rich in cytochrome b5 (cyt b5) [8–10], a small redox protein
which is co-located with P450c17 [9]. Cyt b5 has been implicated in promoting the synthesis of
androgens at the expense of cortisol production [11]. Cyt b5 is a common electron transfer
(redox) protein; however, apo-cyt b5 with no redox activity also enhances androgen synthesis,
suggesting that cyt b5 has an allosteric interaction with P450c17, not a redox interaction [12].
We have shown previously that a double mutant E48G/E49G cyt b5 was unable to stimulate
the 17,20-lyase activity of P450c17 [12]. It has also been shown that cyt b5 interacts directly
with P450c17 [4, 13, 14] and recently, using the soluble domain of cyt b5, that the interaction
site on P450c17 is shared with CPR [4, 15]. Previous research in this area has indicated that cyt
b5 does not alter the active site of P450c17 as the Michaelis constant and substrate binding
affinity were unchanged [16]. Nonetheless, it remains unknown just how cyt b5 regulates the
enzymatic activity of P450c17. Recent work has benefited considerably from the crystal struc-
ture of P450c17 [17], however, despite this structural information questions remain unan-
swered as to the specific protein-protein interactions and regulation of androgen synthesis by
P450c17. Here we investigate the protein-protein interactions to identify how cyt b5 regulates
the 17,20-lyase activity of P450c17; we have conducted studies using in silico docking analysis,
fluorescence resonance energy transfer (FRET) studies, quartz crystal microbalance (QCM)
analyses and electrochemical studies. Together these data show that the cyt b5 interacts with
P450c17 via a well-defined allosteric binding site and dynamically regulates the electrical con-
ductivity of P450c17.
Materials and Methods
Materials
High-purity water (18 MOcm; Sartorius Arium 611) was used for all procedures. KH2PO4
(SigmaAldrich; 99 wt.%), K2HPO4 (SigmaAldrich;  99.9 wt.%), NaCl (Fluka, Ultra,> 99.5
wt.%), H3BO3 (Ajax Finechem), H2SO4 (Univar; 98 wt.%), H2O2 (Merck, Emsure; 30 wt.%
aqueous solution), NH4OH (Ajax Finechem, 28 wt.% aqueous solution), NaOH (SigmaAldrich;
> 97 wt.%), isopropanol (Merck, Epmarta; 99.5%), chloroform (SigmaAldrich; 99%), eth-
anol (Merck, Emsure; absolute), acetone (Merck, Emplura;> 99%), acetonitrile ( 99.9%,
Merck LiChrosolv), methyl tert-butyl ether (Sigma 99.8%), glycerol (Sigma), mercaptopropio-
nic acid (Fluka, BioChimica; 99.0%), hexanethiol (Fluka; 95%), 1,2-dimyristoyl-sn-
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glycero-3-phosphocholine (DMPC) (Avanti polar lipids), cholesterol (SigmaAldrich,
99.0%), polymyxin B sulphate salt (Sigma; 7870 units g-1), hemin (Sigma; porcine, 98%,),
pregnenolone (Steraloids, USA), 17α-hydroxy-pregnenolone (Steraloids, USA), dehydroepian-
drosterone (Steraloids, USA), N,O-bis(trimethylsilyl) trifluoroacetamide (SigmaAldrich; 
99.0%), trimethylchlorosilane (SigmaAldrich; 99.0%), carbon paper (AvCarb P50) were used
as received from the manufacturers. Dichloromethane (MERCK Suprasolv; > 99.9%) was dis-
tilled over CaH2 under a N2 atmosphere prior to use. High-purity nitrogen (99.999%, O2<
2 ppm) was used to remove oxygen from the working electrolyte solutions in voltammetric
studies when required.
Tissue culture materials were purchased from Invitrogen, Fisher, and Sigma. CFP
(eCFP-N1) and YFP (eYFP-N1 and eYFP-C1) vectors were purchased from Clontech (USA).
Solutions of the wild type (wt) and mutant (E42G, E74G, R52G, E48/49G) human cyt b5 were
purified as reported elsewhere [12]. Solutions of recombinant cytochrome P450c17 and CPR
were purified as reported elsewhere [2, 18]. All protein solutions were stored at -80°C in small
aliquots (50–200 μL) and thawed on ice prior to use.
Multiwall carbon nanotubes (CNT; 22 nm average diameter) with impurities less than
1 ppm, were synthesized using a Fe-Co catalyst, boiled in HCl, annealed at 2800°C in a high-
purity Ar atmosphere and characterized following established procedures [19, 20]. The CNT
samples were not ball milled so as to exclude disruption of the regularity or formation of addi-
tional defects on the carbon ‘walls’. Transmission electron microscopic images in Figure A in
S1 File show the fine structure of the heat-treated CNTs.
FRET fusion constructs
The cDNAs encoding human P450c17 and cyt b5 were engineered so as to generate proteins
fused with eYFP or eCFP at the C-terminus, or for cyt b5 at the N-terminus. P450c17 con-
struct was made using the eCFP-N1 vector to make the fluorescent protein as a C-terminal
fusion because the N-terminus of P450c17 encodes the trans-membrane domain. The cyt b5
construct was made using eYFP-C1 vector to make a N-terminal fusion because cyt b5 is
membrane anchored at its carboxy-terminus. The CPR-eYFP C-terminal fusion construct
was donated generously by Dr. Byron Kemper (University of Illinois), and its successful use
in FRET experiments has been described previously [21]. The successful expression of the
fusion constructs was confirmed by western immunoblotting, which demonstrated the
expected increase in molecular size for P450c17 as previously reported [22] and for cyt b5
(Figure B in S1 File). Furthermore these fusion proteins were catalytically active as illustrated
in Figure C in S1 File.
Transfection into cell lines
Transfection of HEK293 was conducted in HyClone (Logan, UT) media with fetal bovine
serum. HEK293 cells (American Type Culture Collection, Manassas, VA) were cultured on Pri-
maria cultureware (BD Biosciences, San Jose, CA) in Dulbecco's Modified Eagle’s Medium
with 5% fetal bovine serum, 10 mMHEPES (pH = 7.4), 100 U ml-1 penicillin, and 100 μg ml-1
streptomycin. After 24 h, cells were transfected (4 μg / 35 mm well) with plasmid fusion con-
structs using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) as suggested by the manufacturer.
For FRET experiments, transfected cells were plated after 18 h into Lab-Tek Chambered Cov-
erglass (1.0 borosilicate coverglass; Nunc, Rochester, NY) at 40% confluence and cultured for
24 h at 37°C.
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Analysis of FRET
FRET was evaluated as previously described from the enhanced acceptor emission [22, 23].
HEK293 cells were transfected with P450c17-eCFP and b5-eYFP plasmids and replated into
Lab-Tek Chambered Coverglass 24 h later. Fluorescence and spectral images (from multiple
cells and multiple experiments) were captured on a computer-controlled, inverted Olympus
IX-81 epifluorescence microscope (Olympus USA, Center Valley, PA) fitted with an Acton
SpectraPro215 spectrograph (Roper Scientific, Tucson, AZ). A mercury light source was used
for excitation in conjunction with filter cubes, containing an excitation filter and dichroic mir-
ror (CFP: excitation filter-D436/20, dichroic-455DCLP; YFP: excitation filter-HQ500/20,
dichroic-Q515LP). Two spectral images of each individual cell, expressing either the CFP con-
struct, the YFP construct, or co-expressing both constructs, were recorded using CFP and YFP
excitation cubes, respectively. FRET data included measurements from 15 different cells taken
from experiments run on 7 different days, each including 1–4 cell recordings. Fluorescence
emission spectra were constructed from spectral images after background subtraction and ana-
lyzed using MetaMorph (Molecular Devices Corp., Sunnyvale, CA) in conjunction with Micro-
soft Excel. FRET ratios were calculated from these spectra.
Structural modeling
Chain A from the crystal structure of Human Cyt P450 17A (PDB code:3swz) [17] was ini-
tially docked onto model 1 of the solution structure of human cyt b5 (PDB code:2i96) [24]
using ZDOCK 3.0.2 [25]. All parameters were kept at default. The 20 lowest energy solutions
were then obtained and visually analyzed. In this analysis, 60% of the solutions showed a sim-
ilar binding mode, thus the lowest energy complex from this cluster was chosen for further
studies. Heme was removed from this complex and then it was submitted to RosettaDock
[26] under default docking parameters. The output energies are listed in Table A in S1 File.
The top 10 scoring solutions were obtained and visually analyzed. There was one major clus-
ter (70%) of solutions, with the highest scoring of these the second lowest energy solution.
This complex was kept for further analysis. Visual analysis was undertaken and figures were
constructed using the PyMOL Molecular Graphics System, Version 1.6.0.0 Schrödinger,
LLC.
Molecular dynamics simulations
The molecular dynamics program NAMD [27] was used to minimize the P450c17:cyt b5 com-
plex. This complex was initially solvated with TIP3P water using the Solvate plugin within
VMD version 1.9. The rotate to minimize volume was selected, the boundary reduced to 1.8
and the box padding increased to 20 Å in all directions; all other parameters were kept at
default. Charges were then neutralized with NaCl using the autoionize plugin within VMD ver-
sion 1.9 using default settings. Each structure was minimized and equalized for 1 nanosecond
(2 femtosecond time step) under the CHARMM27 all-atom force field at 298 K. Langevin
dynamics were used with group pressure and Langevin piston were turned on. Trajectory snap-
shots were collected every picosecond. After approximately 200 picosconds, the average RMSD
had leveled to approximately 2 Å and analysis was conducted after this time point. Hydrogen
bond occupancy was calculated using the Hydrogen Bond plugin in VMD version 1.9 with a
donor-acceptor distance at 3.0 Å and an angle cutoff of 20°. Detailed information was then
selected to be included in the calculation for ‘All H-bonds’.
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Quartz crystal microbalance procedures
QCMmeasurements were undertaken using a Q-sense E4 instrument (Sweden) and quartz
crystal disks coated with a thin Au layer (Q-Sense; diameter ca 1 cm; fundamental resonant fre-
quency 5 MHz) mounted into a cell thermostated at 295 K. This temperature was selected
based on the transition temperature of the lipids used to create a membrane layer, as well as the
lowest temperature to avoid nano-bubbles that could cause difficulties in the QCM apparatus.
Prior to use, gold-coated quartz crystals were cleaned in a NH4OH (28 wt.% aqueous solution):
H2O2 (30 vol.% aqueous solution):H2O (1:1:3 vol.) mixture at 70°C for 15 min, rinsed plenti-
fully with water and isopropanol, and immersed in an isopropanol solution of 1.0 mMmercap-
topropionic acid (mpa) for at least 30 min for formation of a firmly bound mpa layer. Further,
crystals were carefully washed with isopropanol to remove unbound mpa, dried under a gentle
stream of nitrogen and installed in a QCM cell. An Ismatec peristaltic pump (ISM935; Switzer-
land) was used to introduce solutions into the cell. The changes in frequency (ΔfQCM) and dissi-
pation (ΔD) associated with the third, fifth, seventh, and ninth harmonics were recorded
during the experiment, but changes in 7th overtone only are presented and discussed below
(frequency data are reported as normalized ΔfQCM/7 values). After attaining a stable QCM
response in water, 0.1 M NaCl + 0.02 M (K2HPO4+KH2PO4) (pH = 6.9) solution was pumped
through the cell at the flow rate of 0.30 ml min-1 until stable ΔfQCM and ΔD values were
attained. Further, lipid membranes were created on top of the mpa monolayer attached to the
Au-coated quartz crystals by depositing liposomes of 1,2-dimyristoyl-sn-glycero-3-phospho-
choline (DMPC) containing 20 mol.% cholesterol from the 0.1 mM liposome solution in 0.10
M NaCl + 0.02 M (K2HPO4+KH2PO4) (pH = 6.9) pumped through the cell at 0.10 ml min
-1
for 15–25 min following the previously documented protocol [28]. Lipid deposition was fol-
lowed by rinsing the cell with 0.04 M NaCl + 0.008 M (K2HPO4+KH2PO4) (pH = 6.9) solution
at 0.30 ml min-1 for 10–15 min to promote removal of unopened liposomes [29] and then re-
introduction of the 0.10 M NaCl + 0.02 M (K2HPO4+KH2PO4) (pH = 6.9) environment at 0.30
ml min-1 until a stable QCM response was obtained. Finally, ca 1 ml of the protein(s) solution
in 0.10 M NaCl + 0.02 M (K2HPO4+KH2PO4) (pH = 6.9) was pumped through the cell at 0.05
ml min-1. To allow QCM analysis of the structural changes occurring in the lipid layer upon
deposition of protein mixtures over a longer period of time, the outlet of the QCM cell was con-
nected to the inlet after the whole volume of the protein sample was pumped into the appara-
tus, so that the protein-containing solution was continuously circulated through the cell at 0.05
ml min-1 for as long as required.
Electrochemical instrumentation and procedures
Electrochemical measurements were undertaken using either a BAS Epsilon electrochemical
workstation (USA) or a custom-made Fourier transform a.c. voltammetric instrument (Mon-
ash University and LaTrobe University, Australia) [30] in three-electrode cells at ambient tem-
perature (23 ± 1°C). Prior to use, all glassware was filled with the H2SO4 (98 wt.%):H2O2 (30
vol.%) (1:1 vol.) mixture for at least 12 hours, repeatedly washed with ultrapure water and
dried in an oven at 110–120°C. To reduce uncompensated resistance (Ru), aqueous 0.20 M
NaCl + 0.02 M (K2HPO4+KH2PO4) (pH = 7.0) was used as the working electrolyte solution in
all electrochemical experiments.
The high surface area Pt wire (voltammetry) or Pt mesh (controlled potential electrolysis)
auxiliary electrode was immersed in the solution containing electrolyte and separated from the
working electrode compartment by a glass frit. The reference electrode was a AgCl-coated Ag
wire placed in a Luggin capillary also in a solution with electrolyte. This low-impedance refer-
ence electrode is advantageous for a.c. voltammetric measurements. The potential of this
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reference electrode (Ag|AgCl|0.20 NaCl + 0.02 M (K2HPO4+KH2PO4), pH = 7.0) did not vary
between experiments and was 0.078 ± 0.001 V vs. Ag|AgCl|KCl(sat.) (cf. the theoretical value
of 0.080 V) [31]. All potentials are reported versus Ag|AgCl|KCl(sat.) (0.197 V vs. normal
hydrogen electrode) unless otherwise stated.
In the voltammetric studies, gold (nominal diameter 0.2 cm), or glassy carbon (GC; nominal
diameter 0.3 cm) macrodisk electrodes (supplied by BAS (USA)), or a home-made pyrolytic
graphite edge (PGE) or basal plane (PGB) square electrodes (ca 0.2 × 0.2 cm) embedded in an
isolating inert sheath were used as the working electrodes. Prior to use, the surface of the work-
ing electrode was polished with Al2O3 powder (Buehler; 1 μm for PGE and PGB electrodes,
0.3 μm for Au and GC electrodes) using a wet polishing cloth (BAS), then washed, several
times, with water, sonicated in water for ca 20 s (FXP 10M, U-LAB Instruments, Australia),
wiped at least 50 times with a clean wet polishing cloth free of Al2O3, sonicated for another ca
20 s in a fresh portion of H2O, then finally washed again with water. In bulk electrolysis experi-
ments, AvCarb P50 carbon paper (square, ca 0.5 × 0.5 cm) modified with CNTs was used as a
working electrode.
Fabrication of CNT-based electrodes
Deposition of a thin CNT layer on a clean and dry GC electrode surface (ca 30–45 μgCNT cm
-2)
was performed by pipetting small aliquots (ca 0.3 μl) of a suspension of CNTs in isopropanol
(0.10–0.20 mg ml-1) while under a gentle N2 flow to effect rapid drying. Preparation of the
CNT-modified carbon paper electrode (350–400 μgCNT cmgeom.
-2) was undertaken similarly
using larger aliquots (10–20 μl) of the CNT suspension on both sides of the electrode. Prior to
their use, 0.1–0.2 mg ml-1 suspensions of the employed carbon nanotubes in isopropanol were
sonicated for at least 45 min to attain good homogeneity, as exemplified in the photograph in
Figure D in S1 File. However, rapid aggregation of the CNTs occurred after the sonication
ceased. The suspensions were therefore continuously sonication during deposition.
Use of isopropanol did not allow for the selective deposition of the CNT suspension only on
the GC surface, but extended over both conducting carbon surface and the isolating sheath,
even if the smallest aliquots (< 1 μl) were applied to the electrode. Therefore, a CNT layer was
deposited over the whole top surface of an electrode, and the CNTs that deposited on the isolat-
ing sheath were carefully removed using filter paper until only CNTs on a GC surface remained
(Figure D in S1 File).
The high degree of hydrophobicity of the CNTs surface, due to the near perfect structure,
was assessed by the poor wettability of the electrode surface in aqueous solutions. The CNT
surface was made more hydrophilic by dipping the fabricated CNT/GC electrodes into aqueous
glycerol solution (10 vol. %) for 10 min, then washed with water and stored in pure H2O for
not more than 12 h until the experiment.
Fabrication of Au electrodes modified by hexanethiol self-assembled
monolayer
Prior to the deposition of self-assembled monolayers on a Au electrode surface, the electrodes
were cleaned both ‘chemically’ and ‘electrochemically’. First, the electrode was kept in a H2SO4
(98 wt.%): H2O2 (30 vol.%) (1:1 vol.) mixture for at least 12 h; then the Au electrode was used
as a working electrode for multiple cyclic voltammograms (0.020 V s-1) in deaerated aqueous
0.50 M H2SO4 solution over a potential range, 0.05 to 1.6 V vs. reversible hydrogen electrode
(platinized platinum wire in contact with H2-saturated 0.50 M H2SO4) until a stable voltam-
metric response typical of pure polycrystalline gold was obtained.
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Modification of the Au electrodes with a self-assembled monolayer of hexanethiol was
undertaken by dipping a cleaned electrode in the 1–10 mM hexanethiol in isopropanol solution
for 30 min and subsequently washing with copious amounts of pure isopropanol and then
water.
Protein adsorption and characterization of the electrodes
Protein-free electrodes were characterized electrochemically using the deoxygenated or air-sat-
urated electrolyte solutions as appropriate. Protein samples were adsorbed on the electrode sur-
face, over 15–60 min, under ambient conditions from a small aliquot (4–10 μl) of the stock
protein solution. For polymyxin B-assisted adsorption of cyt b5 on PGE electrodes, protein
solutions containing ca 0.13 mM polymyxin B were used and polymixin B was also present in
the electrolyte solution. The protein-modified electrodes were placed in an electrochemical
cell, and the electrolyte solution was deoxygenated by purging with nitrogen for 20 min. In all
measurements, a nitrogen atmosphere was maintained in the cell by slowly purging the gas
above the solution. In some experiments, the voltammetrically characterized protein-modified
electrode was used for further experiments; either for adsorption of another protein and subse-
quent electrochemical characterization, or to test for the catalytic reduction of oxygen in an
air-saturated electrolyte.
Voltammetric simulations
Simulations of voltammograms were performed using the Monash Electrochemistry Simulator
(MECSim) software [32].
Gas chromatographic analysis
Preparation of the samples for the semiquantitative analysis of pregnenolone (preg) and 17α-
hydroxypregnenolone (17-OH-preg) in aqueous solutions included the following procedures:
(i) extraction of the analysed compounds from an aqueous phase to dichloromethane or
methyl tert-butyl ether; (ii) evaporation of the organic solvent under gentle N2 flow and disso-
lution of the solids in CH3CN; (iii) trimethylsilylation of the target compounds with N,O-bis
(trimethylsilyl)trifluoroacetamide (BSTFA) in the presence of 1 vol.% (with respect to BSTFA)
trimethylchlorosilane (TMCS) at 65°C during 30 min (volume proportions were as follows:
0.05 ml of the CH3CN solution + 0.05 ml BSTFA with TMCS). Subsequently, gas chro-
matographic analysis with flame-ionization detector was undertaken under the conditions
reported by Bowden et al. [33]. The derivatization conditions employed were based on results
from Bowden et al. [33].
Results
In vivo FRET
Analysis by FRET of the in vivo protein-protein interactions between P450c17 with CPR using
recombinant constructs to express these proteins in mammalian cells has been previously
reported by some of us [22]. Here we examined the association between P450c17 and wild type
(wt) cyt b5, comparing it with the association of P450c17 and CPR. Non-association of
P450c17 with another steroidogenic cytochrome P450 aromatase (P450arom) was used as a
negative control (Fig 1A). These protein-protein interactions were tested in steroidogenic
(H295) and non-steroidogenic (HEK) cell lines with a similar response. A FRET ratio of>1.0
indicates close association and the apparent FRET efficiency for interaction of P450c17 with wt
Kinetic Role for Cytochrome b5
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Fig 1. FRET ratio data for P450c17 and cyt b5 or CPR. a, The results of FRET pairs expressed in HEK293
or H295 (CPR, H295) cells. Fusion constructs P450c17-eYFP+CPR-eCFP (▲ and▼; positive controls) and
P450c17-eYFP+P450arom-eCFP (&), where P450arom is a negative control.17 Importantly, the
P450c17-eYFP+cytb5-eCFP (♦) have the highest FRET ratio. b,Model of the complex between P450c17
(green) and cyt b5 (magenta) shown in rendered style. Polar interactions are shown as black dashed lines.
Those residues involved in polar interactions are highlighted and labeled individually.
doi:10.1371/journal.pone.0141252.g001
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cyt b5 was significantly greater than with CPR, a clear demonstration of the close association
(heterodimerization) between these two proteins in vivo (Fig 1A).
Structural analysis of the protein-protein interaction sites
Structural analysis of the most likely binding interface between P450c17 and cyt b5 was exam-
ined via computational protein-protein docking. Fig 1B and Figure E in S1 File show that the
P450c17—cyt b5 binding interface is composed of four putative polar interactions between cyt
b5 residues Glu48, Glu49, Glu42 and Asp65 to P450c17 residues Ser427, Arg358, Arg347 and
Lys88, respectively. This agrees well with a recent model by Peng et al. [4], with one additional
interaction between Ser427 and Glu49 postulated in our model. They also reported cross-link-
ing data supporting the close electrostatic interface shared by these two proteins. The specific
cross-linked sites were Lys88-Glu61 and Lys347-Glu42 residues, connecting P450c17 and cyt
b5, respectively [4]. The importance of Glu48 and Glu49 was revealed by mutagenesis with the
double mutant E48G/E49G cyt b5 unable to stimulate the 17,20-lyase activity of P450c17 [12].
This study also suggested that mutation of Glu42 and Asp65 to glycine had an effect on the
stimulation of 17,20-lyase activity, proposed to be due to a reduction in affinity between
P450c17 and cyt b5. Therefore our docking solution agrees well with the previously reported
17,20-lyase activity data. Interestingly, 48 and 49 glutamate residues of cyt b5 were not found
to be cross-linked [4] although clearly they are critical for the androgen synthesis pathway of
P450c17. A further six cyt b5 amino acid mutations that did not influence 17,20-lyase activity
were all remote from this predicted binding interface (Figure F in S1 File) [12].
Notably, mutagenesis of Arg358 and Arg347 amino acids on the P450c17 have been found
to be clinically relevant, and subsequent studies have confirmed that these mutants selectively
diminish 17,20-lyase activity whilst maintaining most of the 17α-hydroxylase activity [34].
Thus, these P450c17 residues are clearly important for interaction with cyt b5. Recent studies
using solution NMR suggested that three arginine residues of P450c17 are important for bind-
ing to cyt b5 [15, 35]. The first two are Arg347 and Arg358, as described above, and the third
residue was Arg449. Although this residue was not directly involved in polar interactions for
the static protein-protein dock conducted in our experiments, the side chain of the Arg449 res-
idue lies in between Arg 358 and Arg347 (Figure G in S1 File). Thus, we conducted a molecular
dynamics simulation to explore this further. Notably, during the 100 ns simulation, the side
chain of Arg449 was involved in a polar interaction with Glu48 approximately 53% of the time
(Table B in S1 File). Thus it is conceivable that in a fluid protein environment, this amino acid
would also play a role in stabilizing the protein-protein interface [15, 35].
Quartz crystal microbalance studies
Specific protein-protein interactions in a physiologically relevant membrane are difficult to
achieve. We have previously used a biomimetic 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC)-cholesterol composite lipid layer to measure specific protein-lipid and protein-pro-
tein interactions for P450c17 and CPR proteins using a QCM [22]. In these studies, solutions
of each purified protein were found to bind tightly to the membrane resulting in a decrease in
the normalized QCM frequency change (ΔfQCM was negative on binding) versus time. The
reproducibility for each individual protein was very good with the introduction of a P450c17
solution showing a ΔfQCM about three times greater than with CPR [22] (data not shown),
despite the distinctly different molecular weights, ~55 and 75 kDa, respectively. Significantly,
addition of CPR to a membrane layer containing P450c17 showed strong binding, indicative of
a specific interaction or heterodimerization between these two proteins [22]. For more details
on the protein-lipid interactions see references [22, 28].
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In the current study we introduced equimolar mixtures of P450c17 and CPR in the presence
or absence of the wt cyt b5 to the DMPC-cholesterol membrane layer and monitored temporal
ΔfQCM and dissipation change (ΔD) profiles as shown in Fig 2A and Figure C, panels a-c in S1
File. The changes in the QCM frequency and dissipation were essentially identical during all
deposition stages (Fig 2A), irrespective of an equimolar or five-fold excess of wt cyt b5. Qualita-
tively these data also resembled profiles for P450c17 solutions binding at a DMPC-cholesterol
membrane [22]. It is noteworthy that a solution containing only the wt cyt b5 also bound
tightly on a DMPC-cholesterol layer, where monotonic changes in ΔfQCM and ΔD character-
ized the protein binding to the membrane (Figure H, panels d and e in S1 File). The QCM data
for P450c17 with CPR mixtures containing different amounts of wt cyt b5 (1:1:1 or 1:1:5 ratio)
showed similar ΔfQCM–ΔD-t profiles and were primarily defined by the interaction of P450c17
(or a P450c17-CPR complex) with the lipid membrane (Fig 2A). Thus the deposition of wt cyt
b5 protein contributed negligibly to the overall QCM profiles in terms of both total amount of
protein deposited (reflected in the ΔfQCM-t data) and the properties of the ensuing protein-
membrane layer (reflected in the ΔD-t data).
A fundamentally different situation was found for mixtures of P450c17 and CPR containing
different concentrations of the E48G/E49G cyt b5 double mutant. Under these conditions, the
rate of ΔfQCM decrease during the first ca 5–10 min of interaction was significantly enhanced,
although the total mass of proteins deposited decreased slightly with an increase in the E48G/
E49G cyt b5 concentration (see Fig 2B and Figure H, panels b and c in S1 File). Changes in the
viscoelastic properties of the protein-lipid layer induced by the presence of E48G/E49G cyt b5
were manifested by differences in the ΔD(t) profiles and final dissipation values were lower for
mixtures of P450c17 + CPR containing the E48G/E49G cyt b5 than solution containing the wt
cyt b5 (Fig 2A and Figure H, panel a in S1 File). The most probable explanation is that the
QCM response arose from the competing deposition of uncoupled (individual) E48G/E49G
cyt b5 and P450c17-based structures or complexes onto the lipid membrane. Thus, the double
mutant cyt b5 bound the membrane more rapidly in sharp contrast to the wt cyt b5 with
P450c17 + CPR solutions. The differences between P450c17 + CPR + wt cyt b5 and P450c17 +
CPR + E48G/E49G cyt b5 mixtures revealed by QCM cannot be readily explained by different
modes of interaction of individual solutions of wt cyt b5 and E48G/E49G cyt b5 with DMPC-
cholesterol composite layer, as those were found to be essentially similar (Figure H, panels d-f
in S1 File).
The QCM data for the mixtures of P450c17 + CPR containing either wt cyt b5 or E48G/
E49G cyt b5 can be rationalized if there was specific coupling between wt cyt b5 and P450c17
(or P450c17-CPR complex). Indeed, based on the QCM data (Fig 2 and Figure C in S1 File), wt
cyt b5 appeared to be incorporated in a ‘protein complex’ structure, in which the interaction
with the lipid membrane was determined by the comparatively large P450c17 enzyme (or even
larger P450c17-CPR complex) and was not influenced by the small cyt b5 protein. This ratio-
nalization also explains the QCM behavior for the E48G/E49G cyt b5 with P450c17 (or
P450c17-CPR complex) with the membrane due to the competition of unbound E48G/E49G
cyt b5. Furthermore, the effect was more marked with an increase in the E48G/E49G cyt b5
concentration.
Supporting the pronounced kinetic differences for protein(s) deposition discussed above,
analysis of these data using ΔfQCM-ΔD profiles compared the structural changes during protein
deposition in terms of stages (see Fig 2B). Importantly, these stages arose during the protein(s)
solution cycling through the QCM chamber and thus reflect the conformational evolution of
the protein-lipid configurations (see Figure H in S1 File). In particular, there were several clear
distinctions in the ΔfQCM-ΔD profiles between solutions containing wt cyt b5 versus E48G/
E49G cyt b5, in stages II–III (Fig 2B). The clearest effect was observed during stage III for a
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Fig 2. Quartz Crystal Microbalance data for proteins binding to a membrane layer. a,QCM data showing changes in frequency (lines, left axes) and
dissipation (symbols, right axes) (7th harmonic; ΔfQCM data are normalized to the overtone number) derived from deposition of proteins onto a DMPC-
cholesterol membrane pre-deposited on a mpa-layer adhered to a Au-coated quartz crystal. QCM profiles obtained with protein mixtures 20 nM P450c17+20
nM CPR+20 nM wt cyt b5 (blue) and 20 nM P450c17 + 20 nM CPR + 100 nM wt cyt b5 (black) were similar to each other and also to that for 20 nM P450c17
+20 nM CPR (Figure H in S1 File). In contrast, the E48G/E49G cyt b5 was deposited non-specifically and competitively with P450c17+CPR, as determined
with 20 nM P450c17+20 nM CPR+20 nM E48G/E49G cyt b5 (green) and especially 20 nM P450c17+20 nM CPR+100 nM E48G/E49G cyt b5 (red) mixtures.
b, Analysis of the QCM data using ΔfQCM vs. ΔD ‘fingerprint’ plots of the temporally resolved data from panel (a). The traces were divided into characteristic
deposition stages labeled with roman numerals (I–III). DMPC = 1,2-dimyristoyl-sn-glycero-3-phosphocholine; mpa = mercaptopropionic acid.
doi:10.1371/journal.pone.0141252.g002
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higher concentration of E48G/E49G cyt b5 in a mixture with P450c17 and CPR. The steady
increase in mass (decrease in ΔfQCM), together with a sustained increase in ΔD was apparent
and consistent with slow non-specific deposition of E48G/E49G cyt b5 on top of the protein-
lipid layer (Fig 2B red trace). Importantly, this contrasted with the P450c17 + CPR + wt cyt b5
mixtures in which no deposition occurred as the mixtures of wt cyt b5 specifically bound to
P450c17 + CPR from the initial solution (Fig 2B black trace). In fact, the negligible changes in
ΔfQCM and the small decrease in ΔD for the wt cyt b5 mixtures reflect the improved protein
organization of the membrane layer gleaned by an overall increased rigidity of the surface.
In summary, QCM studies on the protein-lipid interactions with the P450c17 + CPR mix-
tures containing different ratios of wt cyt b5 or E48G/E49G cyt b5 confirmed the crucial
importance of the glutamic acid residues 48 and 49 for a structural integration of the cyt b5
interaction with P450c17 (or P450c17-CPR complex).
Electrochemical studies
Direct electrochemistry of the proteins could not be achieved efficiently on a supported lipid
bilayer that is effectively an insulator. Biomembrane mimics, including polyions [36], could
also not be used because they ‘trap’ rather than provide a physiological comparison of protein
redox potentials [37]. Therefore, multiwalled carbon nanotube (CNT) based electrodes con-
taining a highly hydrophobic surface, with minimal imperfections [19, 20, 38] were used as a
platform for immobilization of proteins (page S11 in S1 File). Direct current (d.c.) and Fourier
transformed (FT) alternating current (a.c.) [39, 40] voltammetric techniques were employed to
establish the surface concentration of the electrochemically active iron heme and associated
kinetic and thermodynamic parameters of the electron transfer, respectively. Fig 3 (blue data)
shows the d.c. and 6th harmonic components of a.c. cyclic voltammograms for the CNT elec-
trodes modified with P450c17 solution. Surface concentrations of the redox active heme in the
P450c17-modified electrodes were estimated as ca 0.4–0.7 pmol cm2CNT.
In order to be able to identify faradaic response arising from loss of the heme moiety from
either the P450c17 or the cyt b5 proteins in our experiments, we initially studied the voltamme-
try of free hemin adsorbed on CNT-based electrodes. Free hemin showed a well-defined fara-
daic response (Fig 3A and 3B, black traces) with a charge that corresponded to a surface
coverage (Γ) of ca 30–50 pmol cm2CNT representing 0.27–0.45 monolayer coverage. These
results were similar to those reported by Sagara et al. [41] using highly oriented pyrolytic
graphite. The reversible potentials (E0ac) derived from the a.c. voltammetric data obtained with
P450c17 and hemin-modified CNT electrodes are separated by more than 0.02 V (Table 1)
confirming that the surface confined species produced by adsorption of the P450c17 enzyme
and the free heme on the CNTs are not the same.
Table 1 summarizes E0ac data for the individually adsorbed P450c17, wt cyt b5 or E48G/E49G
cyt b5 proteins and hemin. The E0ac values were reproducible to ±0.001 V and an experimentally
distinguishable 0.01 V difference was evident between the wt cyt b5 and the E48G/E49G cyt b5.
Importantly, deposition of P450c17, wt cyt b5 or E48G/E49G cyt b5 on the CNT-based elec-
trodes all produced a surface-confined species, virtually devoid of signals arising from the loss of
heme (Fig 3A and 3B, Table 1). Analysis of the experimental a.c. voltammograms indicated some
heterogeneity of these modified electrodes as expected [42]. Further discussion of the modes of
adsorption of the proteins on the CNT surface is provided in the Supplementary Information
(Figures I-K, Table C and accompanying discussion on pages S14-S15 in S1 File).
E0ac values discussed above were compared with those found upon addition of wt or E48G/
E49G cyt b5 proteins to CNTs pre-modified with P450c17 (Table 1 and Fig 3C and 3D). Signif-
icantly, these voltammetric data show that adsorption of the wt cyt b5 did not change or just
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Fig 3. Cyclic voltammetric analysis of P450c17, wt cyt b5, E48G/E49G cyt b5 and sequential additions. a, c, d.c. voltammograms and b, d, the 6th
harmonic of the a.c. voltammograms for the bare (grey; left axis) and modified CNT electrodes. a, b, Adsorption of hemin (black, right axes) produced a much
larger faradaic current and an E0ac value (dashed lines) that were at least 0.02 V more negative than those derived from adsorption of proteins (left axes): wt
cyt b5 (green), E48G/E49G cyt b5 (red) or P450c17 (blue). c, Adsorption of E48G/E49G cyt b5 on P450c17/CNT (blue) produced a substantial increase in
the surface concentration of hemin (orange), but negligible changes in Γ were derived from adsorption of wt cyt b5 (magenta) on P450c17/CNT. d, The
faradaic current in the a.c. components for P450c17 (blue) was suppressed upon interaction with wt cyt b5 (magenta); the a.c. data for wt cyt b5 (green) is
shown as a control. (e) Schematic representation of the modes of interaction of the wt cyt b5 and the E48G/E49G cyt b5 with the P450c17/CNT electrode. All
currents were normalized to the geometric electrode surface area (a-c) or to the amount of electroactive heme (d); The electrolyte solution in each case was a
deoxygenated aqueous 0.20 M NaCl+0.02 M (K2HPO4+KH2PO4), pH = 7.0.
doi:10.1371/journal.pone.0141252.g003
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slightly decreased (by 0–5%) the surface concentration, Γ, of the electrochemically active heme
(Fig 3C magenta trace). This contrasted with the pronounced enhancement in Γ upon modifi-
cation of the P450c17/CNT electrode assembly with E48G/E49G cyt b5 (Fig 3C orange trace).
Thus, the voltammetric data indicated that the E48G/E49G cyt b5 was immobilized on the
CNT surface with no specific interaction with the P450c17. These results are in good agreement
with the QCM studies using a lipid layer.
To further explore the nature of the interaction between wt cyt b5 and the P450c17-modi-
fied electrodes we used simultaneous analysis of both d.c. (Fig 3C) and a.c. voltammetric data
(Fig 3D). While the d.c. component showed no or very small decrease in protein coverage, Γ
(Fig 3C, wt cyt b5/P450c17/CNT, magenta trace vs. P450c17/CNT alone, blue trace), the a.c.
voltammograms exhibited an accompanying significant suppression of the harmonic compo-
nents by 35 ± 6% reflecting a deceleration of the electron transfer kinetics (Fig 3D, wt cyt b5/
P450c17/CNT, magenta trace vs. P450c17/CNT alone, blue trace). The shape of the a.c. fara-
daic signal is highly sensitive to the nature of the redox process, and is expected to change sub-
stantially when mixed adsorbates with different signatures are introduced. Importantly, this
was not found when wt cyt b5 was added to P450c17/CNT. Furthermore, no positive shift of
the reversible potential was observed as would be expected if cyt b5 was adsorbed directly on
the CNTs (see Table 1; Fig 3D, green trace). Thus, the FT a.c. voltammetry observations sup-
port preferential deposition of ‘electrochemically silent’ wt cyt b5 on the surface of electroactive
P450c17, in confirmation of negligible changes in the d.c. faradaic charge. Taken together, the
a.c. and d.c. voltammetry data suggest that the effect of wt cyt b5 addition on a P450c17-CNT
electrode is the modulation of the charge transfer kinetics associated with P450c17 protein
complex(es) as illustrated in Fig 3E. The significant differences in the adsorption of the wild
type and E48G/E49G cyt b5 proteins on the P450c17-modified electrodes also indicated that
the P450c17 enzyme experienced no structural damage upon adsorption on the CNT (see
Fig 3C).
Discussion
Despite the decade long knowledge that cyt b5 plays a significant role in the 17,20-lyase reac-
tion of P450c17 and hence androgen synthesis, the nature of this interaction and regulatory
Table 1. Reversible potentials (E0ac) of the surface confined Fe
3+/2+ redox couple derived from the a.c.
voltammograms (f = 219 Hz)a obtained from CNT electrodesmodified with hemin, wt cyt b5, E48G/
E49G cyt b5, P450c17, and their combinations.
Adsorbed Species E0ac / V vs. Ag|AgCl|KCl(sat.)
b
hemin -0.318
wt cyt b5 -0.285
hemin / wt cyt b5 c -0.319
E48G/E49G cyt b5 -0.295
P450c17 -0.296
wt cyt b5 / P450c17 d -0.296
E48G/E49G cyt b5 / P450c17 d -0.295
a Average of the potentials of the central minimum in the 6th a.c. harmonic (envelope presentation, in Fig 3)
from the forward and backward d.c. potential sweep directions.
b Values are reproducible to ±0.001 V.
c Hemin adsorbed on the electrode pre-modified with wt cyt b5.
d either wt or E48G/E49G cyt b5 adsorbed on the electrode pre-modified with P450c17.
doi:10.1371/journal.pone.0141252.t001
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mechanism has not been identified. We have approached this problem using a number of com-
plementary in silico, in vivo and in vitro techniques in order to provide a comprehensive bio-
physical analysis.
The FRET analyses in living cells showed a heterodimeric interaction between P450c17 and
cyt b5 and were conducted [22], but not reported previously, as part of an examination of ste-
roidogenic P450 enzyme interactions. It is known that proteins can form nonspecific aggre-
gates at high expression levels [43] but the lack of heterodimerization between P450c17 and
P450arom, as shown previously [22], argues strongly that the FRET complexes detected here
for P450c17 and cyt b5 result from highly specific interactions. Furthermore, the FRET com-
plexes observed between P450c17 and CPR were as expected from functional studies. Impor-
tantly, the FRET level of P450c17 with cyt b5 was much greater than even with CPR, clearly
indicating that a close and specific binding of cyt b5 and P450c17 occurs in live cells.
Computational docking predicted the binding interface and key interactions. The predicted
major contributors to the binding energy are polar interactions between cyt b5 residues Glu48,
Glu49, Glu42 and Asp65 to P450c17 residues Ser427, Arg358, Arg347 and Lys88, respectively.
The good agreement with the recent cross-linking studies by Peng et al. [4] provided confi-
dence in our model. Importantly, the modeling also predicted that E48G/E49G cyt b5 would
not form an energetically favorable association with P450c17.
QCM analyses were conducted using a composite DMPC-cholesterol lipid bilayer to mimic
protein interactions as might occur in vivo. Our earlier studies using P450c17 showed the spe-
cific interactions between P450c17 with CPR [22] but were not extended to cyt b5. NMR stud-
ies probing the interaction between P450c17 and cyt b5 have been conducted in solution [15,
35]. These experiments were conducted using a soluble, carboxy-terminally truncated form of
cyt b5 that has only 1/6th of the capacity to stimulate 17,20-lyase activity of P450c17 [44].
Hence protein interactions observed previously might not have accurately reflected those that
occur in vivo. Thus, we compared the protein-protein interactions between the wt cyt b5 or
E48G/E49G cyt b5 with P450c17 + CPR complexes on a biomimetic membrane using a QCM.
In the case of wt cyt b5, the protein deposition fingerprint (Δf-t, ΔD-t and Δf-ΔD in Fig 2) indi-
cated that the wt cyt b5 specifically bound to P450c17 + CPR complexes formed in the initial
solution and therefore co-deposited into the membrane modified QCM sensor. In contrast, the
E48G/E49G cyt b5 deposited more rapidly and non-specifically to the membrane and co-
deposited competitively with P450c17 + CPR. Further evidence was gleaned with the concen-
tration-dependent binding for the E48G/E49G cyt b5 deposition. Thus, the QCM data support
the concept that wt cyt b5 interacts specifically with the P450c17 in the membrane and further-
more agrees well with our in silicomodel. Importantly, the QCM data highlighted the crucial
importance of an electrostatic network within the interfacial domains between wt cyt b5 with
P450c17 and specifically the glutamic acid residues 48 and 49 on the cyt b5 for protein-protein
interactions in a membrane.
Direct electrochemical studies specifically enabled us to demonstrate that adsorption of the
wt cyt b5 on the P450c17/CNT composite decreased the rate of the electron transfer between
P450c17 and the electrode, although the wt cyt b5 itself was electrochemically inactive. This
effect is consistent with wt cyt b5 acting allosterically on P450c17. In contrast, E48G/E49G cyt
b5 adsorbed non-specifically and did not have an effect on P450c17 electrochemistry, support-
ing the claim that the effect of wt cyt b5 on P450c17 was specific. Thus, these electrochemical
experiments illustrate modulation of the electron transfer properties of P450c17 with and with-
out cyt b5 and illustrate that this direct interaction requires the E48 and E49 residues.
The slower electron transfer kinetics for the P450c17/CNT electrodes upon adsorption of
wt cyt b5 (Fig 3D) is most likely of ‘biological’ origin, i.e. reflects the kinetic effect of protein-
protein interaction on the rate of electron transfer in (and out of) the heme moiety (Fig 3E).
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Alternative ‘physicochemical’ origins, due to surface effects of the electrode are less likely. In
principle, the magnitude of the a.c. current might be modulated due to changes in heterogene-
ity of the surface-confined protein upon adsorption of foreign species. However, the voltam-
metric data were reproducible in terms of (i) negligible changes in the faradaic d.c. charge (0–
5%), (ii) the decrease in the faradaic a.c. current (35 ± 6%), (iii) maintaining the shape of har-
monics, and (iv) no change in E0ac. Physicochemical effects are typically more erratic in nature
and do not explain these data. Thus, we attribute the role of cyt b5 as regulating the rate of elec-
tron movement for P450c17.
It has been long suggested that the interaction of P450c17 and cyt b5 induces conforma-
tional changes in P450c17 as part of its mechanism of action [5]. Our electrochemistry data
provides the first functional evidence to support the suggestion that changes in the conforma-
tion of P450c17 account for the slowing in the rate of electron transfer between P450c17 and
the electrode or another molecule.
In summary, our comprehensive examination of the interaction between P450c17 with CPR
and either wt cyt b5 or a functionally defective mutant E48G/E49G cyt b5 employed four bio-
physical approaches. FRET analysis was used to examine interactions within living cells and in
silicomodeling identified the sites of interaction likely to be disrupted between the E48G/E49G
cyt b5 and P450c17. QCM identified specific protein-protein interactions in a biomimetic lipid
membrane and combined d.c. and a.c. voltammetric analysis revealed that the wt cyt b5, but
not E48G/E49G cyt b5, altered the kinetics of electron transfer between the electrode and the
P450c17. This hitherto unknown effect of cyt b5 on the electron transfer kinetics of P450c17
provides novel mechanistic insight into how cyt b5 regulates the 17,20 lyase activity of
P450c17.
Supporting Information
S1 File. Supporting Information.pdf, contains: Table A: Output energies for the top 10
poses from RosettaDock; Figure A: TEM images of CNTs; Figure B: Western immunoblot
of cyt b5; Figure C: Activity of P450c17-eCFP and P450c17-eYFP using pregnenolone as
the substrate; Figure D: Photographs of the CNT suspension and CNT-modified GC elec-
trode; Figure E: Stereo images of the P450c17 (green) and cyt b5 (magenta) model complex
in Fig 1B; Figure F: Mutated residues of cyt b5; Figure G: Arg449 position in the protein-
protein interface; Table S2B: Percentage occupancy of hydrogen bonds between the inter-
face of P450c17 and cyt b5 during the molecular dynamics simulations; Figure H: QCM
data; Supplementary discussions: Choosing an electrode platform for probing the P450c17
and cyt b5 electrochemistry; Figure I: Electrocatalytic properties of P450c17 adsorbed on
CNT; Figure J: Oxygen electroreduction catalyzed by protein- and hemin-modified CNT
electrodes; Supplementary discussions: Enzymatic capacity of P450c17 immobilized on a
CNT-based electrode; Supplementary discussions: Adsorption of cyt b5 on bare CNT-
based electrodes; Figure K: Electrochemistry of cyt b5-polymyxin B films; Table C: Revers-
ible potentials (E0ac) for PGE electrodes modified with cyt b5 with polymyxin B films; List
of abbreviations; Supplementary references.
(PDF)
Acknowledgments
LLM and AMB thank the Australian Research Council, RJR the National Health and Medical
Research Council and RJA the National Institutes of Health (R01GM086596) for funding. Gen-
erous gifts of a carbon cloth from Dr. Thomas Rüther (CSIRO, Clayton, Australia) and hemin
Kinetic Role for Cytochrome b5
PLOSONE | DOI:10.1371/journal.pone.0141252 November 20, 2015 16 / 19
from A/Professor Bayden Wood (Monash University, Clayton, Australia) are gratefully appre-
ciated. We would like to also thank Dr’s Slavica Praporski, Andrew Abell, Jonathon Baell, Eliz-
abeth Yuriev, Grant Booker and Ms. Kelly Keeling for their contributions and/or valuable
discussions. Infrastructure support from the National Health and Medical Research Council
(NHMRC) Independent Research Institutes Infrastructure Support Scheme and the Victorian
State Government Operational Infrastructure Support Program to St Vincent’s Institute are
gratefully acknowledged. JKH is a joint Cure Cancer/ Leukaemia Foundation Postgraduate Fel-
low and MWP is a NHMRC Senior Principal Research Fellow.
Author Contributions
Conceived and designed the experiments: ANS JKH AJC MWP RJR LLM. Performed the
experiments: ANS JKH JCIY ADN CJC. Analyzed the data: ANS JKH ADN CJC AJC MWP
RJR LLM. Contributed reagents/materials/analysis tools: JZ VLK RJA AMB. Wrote the paper:
ANS JKH AJC MWP RJR LLM.
References
1. Ortiz de Montellano PR. Cytochrome P450: structure, mechanism, and biochemistry, 3rd ed.. New
York: Kluwer Academic/Plenum Publishers; 2005. 689 p.
2. Corbin CJ, Moran FM, Vidal JD, Ford JJ, Wise T, Mapes SM, et al. Biochemical Assessment of Limits
to Estrogen Synthesis in Porcine Follicles. Biology of Reproduction. 2003; 69(2):390–7. doi: 10.1095/
biolreprod.103.015578 PMID: 12672661
3. Moran FM, Ford JJ, Corbin CJ, Mapes SM, Njar VC, Brodie AM, et al. Regulation of Microsomal P450,
Redox Partner Proteins, and Steroidogenesis in the Developing Testes of the Neonatal Pig. Endocrinol-
ogy. 2002; 143(9):3361–9. doi: 10.1210/en.2002-220329 PMID: 12193548.
4. Peng H-M, Liu J, Forsberg SE, Tran HT, Anderson SM, Auchus RJ. Catalytically Relevant Electrostatic
Interactions of Cytochrome P450c17 (CYP17A1) and Cytochrome b5. Journal of Biological Chemistry.
2014; 289(49):33838–49. doi: 10.1074/jbc.M114.608919 PMID: 25315771
5. Miller WL, Auchus RJ. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogene-
sis and Its Disorders. Endocrine reviews. 2011; 32(1):81–151. doi: 10.1210/er.2010-0013 PMID:
WOS:000287022600005.
6. Yoshimoto FK, Auchus RJ. The diverse chemistry of cytochrome P450 17A1 (P450c17, CYP17A1).
The Journal of steroid biochemistry and molecular biology. 2015; 151:52–65. doi: http://dx.doi.org/10.
1016/j.jsbmb.2014.11.026 PMID: 25482340
7. Lee-Robichaud P, Akhtar ME, Wright JN, Sheikh QI, Akhtar M. The cationic charges on Arg347,
Arg358 and Arg449 of human cytochrome P450c17 (CYP17) are essential for the enzyme's cyto-
chrome b5-dependent acyl-carbon cleavage activities. The Journal of steroid biochemistry and molecu-
lar biology. 2004; 92(3):119–30. Epub 2004/11/24. doi: 10.1016/j.jsbmb.2004.07.005 PMID: 15555906.
8. Mapes S, Corbin CJ, Tarantal A, Conley A. The Primate Adrenal Zona Reticularis is Defined by Expres-
sion of Cytochrome b5, 17α-hydroxylase/17,20-lyase Cytochrome P450 (P450c17) and NADPH-Cyto-
chrome P450 Reductase (reductase) but not 3β-Hydroxysteroid Dehydrogenase/Δ5–4 Isomerase (3β-
HSD). The Journal of Clinical Endocrinology & Metabolism. 1999; 84(9):3382–5. doi: 10.1210/jcem.84.
9.6105 PMID: 10487714
9. Dharia S, Slane A, Jian M, Conner M, Conley AJ, Parker CR. Colocalization of P450c17 and Cyto-
chrome b5 in Androgen-Synthesizing Tissues of the Human. Biology of Reproduction. 2004; 71(1):83–
8. doi: 10.1095/biolreprod.103.026732 PMID: 14985252
10. Nguyen AD, Mapes SM, Corbin CJ, Conley AJ. Morphological adrenarche in rhesus macaques: devel-
opment of the zona reticularis is concurrent with fetal zone regression in the early neonatal period. Jour-
nal of Endocrinology. 2008; 199(3):367–78. doi: 10.1677/joe-08-0337 PMID: 18787057
11. Nguyen AD, Corbin CJ, Pattison JC, Bird IM, Conley AJ. The Developmental Increase in Adrenocortical
17,20-Lyase Activity (Biochemical Adrenarche) Is Driven Primarily by Increasing Cytochrome b5 in
Neonatal Rhesus Macaques. Endocrinology. 2009; 150(4):1748–56. doi: 10.1210/en.2008-1303
PMID: 19036885
12. Naffin-Olivos JL, Auchus RJ. Human Cytochrome b5 Requires Residues E48 and E49 to Stimulate the
17,20-Lyase Activity of Cytochrome P450c17†. Biochemistry. 2006; 45(3):755–62. doi: 10.1021/
bi051623y PMID: 16411751
Kinetic Role for Cytochrome b5
PLOSONE | DOI:10.1371/journal.pone.0141252 November 20, 2015 17 / 19
13. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis
and its disorders. Endocrine reviews. 2011; 32(1):81–151. Epub 2010/11/06. doi: 10.1210/er.2010-
0013 PMID: 21051590; PubMed Central PMCID: PMCPmc3365799.
14. Storbeck KH, Swart AC, Goosen P, Swart P. Cytochrome b5: novel roles in steroidogenesis. Molecular
and cellular endocrinology. 2013; 371(1–2):87–99. Epub 2012/12/12. doi: 10.1016/j.mce.2012.11.020
PMID: 23228600.
15. Estrada DF, Laurence JS, Scott EE. Substrate-modulated Cytochrome P450 17A1 and Cytochrome b5
Interactions Revealed by NMR. Journal of Biological Chemistry. 2013; 288(23):17008–18. doi: 10.
1074/jbc.M113.468926 PMID: 23620596
16. Akhtar MK, Kelly SL, Kaderbhai MA. Cytochrome b(5) modulation of 17{alpha} hydroxylase and 17–20
lyase (CYP17) activities in steroidogenesis. The Journal of endocrinology. 2005; 187(2):267–74. Epub
2005/11/19. doi: 10.1677/joe.1.06375 PMID: 16293774.
17. DeVore NM, Scott EE. Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone
and TOK-001. Nature. 2012; 482(7383):116–9. doi: http://www.nature.com/nature/journal/v482/n7383/
abs/nature10743.html#supplementary-information. doi: 10.1038/nature10743 PMID: 22266943
18. Johnson DL, Conley AJ, Martin LL. Direct electrochemistry of human, bovine and porcine cytochrome
P450c17. Journal of Molecular Endocrinology. 2006; 36(2):349–59. PMID: 16595705
19. Kuznetsov VL, Elumeeva KV, Ishchenko AV, Beylina NY, Stepashkin AA, Moseenkov SI, et al. Multi-
walled carbon nanotubes with ppm level of impurities. physica status solidi (b). 2010; 247(11–
12):2695–9. doi: 10.1002/pssb.201000211
20. Elumeeva KV, Kuznetsov VL, Ischenko AV, Smajda R, Spina M, Forró L, et al. Reinforcement of CVD
grown multi-walled carbon nanotubes by high temperature annealing. AIP Advances. 2013; 3
(11):112101. doi: http://dx.doi.org/10.1063/1.4829272
21. Szczesna-Skorupa E, Mallah B, Kemper B. Fluorescence Resonance Energy Transfer Analysis of
Cytochromes P450 2C2 and 2E1 Molecular Interactions in Living Cells. Journal of Biological Chemistry.
2003; 278(33):31269–76. PMID: 12766165
22. Praporski S, Ng SM, Nguyen AD, Corbin CJ, Mechler A, Zheng J, et al. Organization of Cytochrome
P450 Enzymes Involved in Sex Steroid Synthesis: PROTEIN-PROTEIN INTERACTIONS IN LIPID
MEMBRANES. Journal of Biological Chemistry. 2009; 284(48):33224–32. doi: 10.1074/jbc.M109.
006064 PMID: 19805543
23. Takanishi CL, Bykova EA, ChengW, Zheng J. GFP-based FRET analysis in live cells. Brain Research.
2006; 1091(1):132–9. doi: http://dx.doi.org/10.1016/j.brainres.2006.01.119 PMID: 16529720
24. Nunez-Quintana M, Truan G, Van Heijenoort C. Solution structure of human cytochrome b5. doi: 10.
2210/pdb2i96/pdb
25. Pierce BG, Wiehe K, Hwang H, Kim B-H, Vreven T, Weng Z. ZDOCK server: interactive docking predic-
tion of protein–protein complexes and symmetric multimers. Bioinformatics. 2014; 30(12):1771–3. doi:
10.1093/bioinformatics/btu097 PMID: 24532726
26. Lyskov S, Gray JJ. The RosettaDock server for local protein–protein docking. Nucleic Acids Research.
2008; 36(suppl 2):W233–W8.
27. Phillips JC, Braun R, WangW, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics
with NAMD. Journal of computational chemistry. 2005; 26(16):1781–802. doi: 10.1002/jcc.20289
PMID: 16222654; PubMed Central PMCID: PMC2486339.
28. Mechler A, Praporski S, Piantavigna S, Heaton SM, Hall KN, Aguilar M-I, et al. Structure and homoge-
neity of pseudo-physiological phospholipid bilayers and their deposition characteristics on carboxylic
acid terminated self-assembled monolayers. Biomaterials. 2009; 30(4):682–9. doi: http://dx.doi.org/10.
1016/j.biomaterials.2008.10.016 PMID: 19000635
29. Knappe D, Piantavigna S, Hansen A, Mechler A, Binas A, Nolte O, et al. Oncocin
(VDKPPYLPRPRPPRRIYNR-NH2): A Novel Antibacterial Peptide Optimized against Gram-Negative
Human Pathogens. Journal of Medicinal Chemistry. 2010; 53(14):5240–7. doi: 10.1021/jm100378b
PMID: 20565063
30. Bond AM, Duffy NW, Guo S-X, Zhang J, Elton D. Changing the Look of Voltammetry. Analytical Chem-
istry. 2005; 77(9):186 A-95 A. doi: 10.1021/ac053370k
31. Bard AJ, Faulkner LR. Electrochemical Methods: Fundamentals and Applications 2nd ed. New York,
USA JohnWiley & Sons, Inc.; 2001.
32. Kennedy GF. Monash Electrochemistry Simulator (MECSim). Available: http://www.garethkennedy.
net/MECSim.html. Accessed 2015 May 11.
33. Bowden JA, Colosi DM, Mora-Montero DC, Garrett TJ, Yost RA. Enhancement of chemical derivatiza-
tion of steroids by gas chromatography/mass spectrometry (GC/MS). Journal of Chromatography B.
2009; 877(27):3237–42. doi: http://dx.doi.org/10.1016/j.jchromb.2009.08.005
Kinetic Role for Cytochrome b5
PLOSONE | DOI:10.1371/journal.pone.0141252 November 20, 2015 18 / 19
34. Gupta MK, Geller DH, Auchus RJ. Pitfalls in characterizing P450c17 mutations associated with isolated
17,20-lyase deficiency. The Journal of clinical endocrinology and metabolism. 2001; 86(9):4416–23.
Epub 2001/09/11. doi: 10.1210/jcem.86.9.7812 PMID: 11549685.
35. Estrada DF, Skinner AL, Laurence JS, Scott EE. Human Cytochrome P450 17A1 Conformational
Selection: MODULATION BY LIGAND AND CYTOCHROME b5. Journal of Biological Chemistry.
2014; 289(20):14310–20. doi: 10.1074/jbc.M114.560144 PMID: 24671419
36. Rusling JF, Forster RJ. Electrochemical catalysis with redox polymer and polyion-protein films. Journal
of colloid and interface science. 2003; 262(1):1–15. Epub 2005/11/01. doi: 10.1016/s0021-9797(03)
00148-6 PMID: 16256574.
37. Fleming BD, Bond AM, Martin LL. The Electrochemistry of Cytochrome P450 (Ch. 5) in The Ubiquitous
Roles of Cytochrome P450 Proteins Vol. 3. Sigel AS, Sigel H., R.K.O., editor. Chichester: JohnWiley
& Sons; 2007.
38. Cherstiouk OV, Kuznetsov VL, Simonov AN, Mazov IN, Elumeeva KV, Moseva NS. Electrocorrosion
properties of multiwall carbon nanotubes. physica status solidi (b). 2010; 247(11–12):2738–42. doi: 10.
1002/pssb.201000352
39. Bond AM, Mashkina EA, Simonov AN. A Critical Review of the Methods Available for Quantitative Eval-
uation of Electrode Kinetics at Stationary Macrodisk Electrodes. Developments in Electrochemistry:
JohnWiley & Sons, Ltd; 2014. p. 21–47.
40. Bond AM, Elton D, Guo S-X, Kennedy GF, Mashkina E, Simonov AN, et al. An integrated instrumental
and theoretical approach to quantitative electrode kinetic studies based on large amplitude Fourier
transformed a.c. voltammetry: A mini review. Electrochemistry Communications. 2015; 57(0):78–83.
doi: http://dx.doi.org/10.1016/j.elecom.2015.04.017
41. Sagara T, Fukuda M, Nakashima N. Electroreflectance Study of Hemin Adsorbed on a HOPGElec-
trode: Estimation of Molecular Orientation and Analysis of Nonfaradaic Electroreflectance Signal Due
to the Stark Effect. The Journal of Physical Chemistry B. 1998; 102(3):521–7. doi: 10.1021/jp9713928
42. Simonov AN, GrosseW, Mashkina EA, Bethwaite B, Tan J, Abramson D, et al. New Insights into the
Analysis of the Electrode Kinetics of Flavin Adenine Dinucleotide Redox Center of Glucose Oxidase
Immobilized on Carbon Electrodes. Langmuir. 2014; 30(11):3264–73. doi: 10.1021/la404872p PMID:
24571209
43. Ozalp C, Szczesna-Skorupa E, Kemper B. Bimolecular fluorescence complementation analysis of cyto-
chrome p450 2c2, 2e1, and NADPH-cytochrome p450 reductase molecular interactions in living cells.
Drug metabolism and disposition: the biological fate of chemicals. 2005; 33(9):1382–90. Epub 2005/06/
28. doi: 10.1124/dmd.105.005538 PMID: 15980100.
44. Holmans PL, Shet MS, Martinwixtrom CA, Fisher CW, Estabrook RW. The High-Level Expression in
Escherichia coli of the Membrane-Bound Form of Human and Rat Cytochrome b5 and Studies on Their
Mechanism of Function. Archives of Biochemistry and Biophysics. 1994; 312(2):554–65. doi: http://dx.
doi.org/10.1006/abbi.1994.1345 PMID: 8037471
Kinetic Role for Cytochrome b5
PLOSONE | DOI:10.1371/journal.pone.0141252 November 20, 2015 19 / 19
